Sven Becker

No ORCID on file · 12 papers in corpus · active 2011-2026

Study types

  • article 4
  • other 3
  • case-report 1
  • editorial 1
  • rct 1

Condition tags

  • endometriosis 8
  • infertility 3
  • mesh:D004715 3
  • dysmenorrhea 2
  • adenomyosis 2
  • die_deep_infiltrating 1
  • dyspareunia 1
  • bowel_endometriosis 1
other 2026
Linzagolix, with and without add-back therapy, in women with endometriosis-associated pain: results from EDELWEISS 6, a double-blind randomized extension and withdrawal study
Human reproduction open ·doi:10.1093/hropen/hoag030

STUDY QUESTION: Was the efficacy of linzagolix, observed at 6 months in women with endometriosis-associated pain, maintained when administered for an additional 6 months? SUMMARY ANSWER: Efficacy from this extension study complements the r…

other 2025
Laparoscopic Endometriosis Surgery in Patients with Infertility: Identifying Surgical and Non-Surgical Variables Affecting Postoperative Pregnancy. Long-term Follow-up in a University Endometriosis Center
Geburtshilfe und Frauenheilkunde ·doi:10.1055/a-2460-6470

BACKGROUND: Endometriosis is a disease which affects the quality of life and fertility of many young women. Choosing the right time for surgery is important for the outcome of patients. We evaluated the surgical variables affecting postoper…

rct 2025
Linzagolix with and without hormonal add-back therapy for symptomatic uterine fibroids: PRIMROSE 1 & 2 long-term extension and withdrawal study
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.06.016

OBJECTIVE: To evaluate whether oral linzagolix administered once daily for up to 52 weeks (extension study) at a dose of 100 mg or 200 mg with or without hormonal add-back therapy (ABT) (1.0 mg estradiol; 0.5 mg norethisterone acetate) can …

other 2025
Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials
Human reproduction open ·doi:10.1093/hropen/hoaf025

STUDY QUESTION: How important was the change in lumbar spine (L1-L4), femoral neck, and total hip bone mineral density (BMD) from post-treatment baseline values to 24 months after the end of treatment in PRIMROSE 1 and PRIMROSE 2 study part…

article 2024
Postoperative Reproductive Outcomes in Patients with Endometriosis-Associated Infertility: A Single-Center Retrospective Study
Gynecologic and obstetric investigation ·doi:10.1159/000539142

OBJECTIVES: Endometriosis is a chronic inflammatory disease known to contribute to infertility. Laparoscopic excision of endometriotic lesions represents a standard treatment modality for symptomatic women. Our study aims to assess the pote…

article 2024
Therapy Response and Survival among Patients with Gynecologic Tumors Treated with Transarterial Chemoperfusion and Transarterial Chemoembolization
·doi:10.3390/medicina60101585

Background and Objectives: This study aimed to evaluate the tumor response relating to and survival benefit of transarterial chemoperfusion (TACP) and transarterial chemoembolization (TACE) in the treatment of patients with unresectable gyn…

2023
Hormonal Contraception and the Risk of Breast Cancer in Women of Reproductive Age: A Meta-Analysis.
Cancers ·doi:10.3390/cancers15235624
article 2023
Pregnancy after laparoscopic surgery for endometriosis: How long should we wait? A retrospective study involving a long‐term follow up at a university endometriosis center
International Journal of Gynecology & Obstetrics ·doi:10.1002/ijgo.14849

Abstract Objective To find the factors that influence the time until pregnancy after laparoscopic intervention and to evaluate the proper time to start assisted reproductive therapy (ART). Methods This is a retrospective analysis that inclu…

editorial 2018
Adenomyosis and Myomata: Risks, Problems, and Complications in Diagnosis and Therapy of Adenomyosis and Myomata
BioMed research international ·doi:10.1155/2018/5952460

The goal of this special issue is to address research concerning risks and problems related to the diagnosis and therapy of adenomyosis and myomata. During the last years, there have been several controversies in the scientific community re…

article 2018
The cost-effective, but forgotten, medical endometriosis therapy: a prospective, quasi-randomized study on progestin therapy.
Facts, views & vision in ObGyn

Endometriosis represents nowadays a real burden for the patients as well as for the physicians, as it requires surgical and/or medical treatment, often long - termed and repeated. Moreover, the high costs necessary to diagnose and treat end…

review 2017
From Clinical Symptoms to MR Imaging: Diagnostic Steps in Adenomyosis
BioMed research international ·doi:10.1155/2017/1514029

Adenomyosis or endometriosis genitalis interna is a frequent benign disease of women in fertile age. It causes symptoms like bleeding disorders and dysmenorrhea and seems to have a negative effect on fertility. Adenomyosis can be part of a …

case-report 2011
Lower extremity compartment syndrome after laparoscopic radical hysterectomy: brief report of an unusual complication of laparoscopic positioning requirements
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2011.03.016

Compartment syndrome of the lower extremities is a clinically and medicolegally potentially devastating complication. Recently, the more widespread use of advanced laparoscopic surgical techniques, dealing with complex gynecologic diseases,…